Meysam Soleimani

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Coronavirus Disease

High Efficiency

Long Noncoding Rna

Top Venues

Iranian journal of pharmaceutical research : IJPR

Future virology

Medical oncology (Northwood, London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Fatemeh Heidari, Soheil Madadi, Neda Alizadeh, Mohammad Hossein Alimardani, Armin Safari, Mohammad Hossein Armand, Elahe Pishgahzadeh, Meysam Soleimani
The potential of monoclonal antibodies for colorectal cancer therapy. Medical oncology (Northwood, London, England) 40 (9) (2023)
Farnosh Darabi, Massoud Saidijam, Fatemeh Nouri, Reza Mahjub, Meysam Soleimani
Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and In Vitro Characterization. BioMed research international 2022 (2022)
Ali Bahrami, Mohammad Taheri, Mohammad Reza Arabestani, Meysam Soleimani, Mojdeh Mohammadi, Fatemeh Golabchi, Maryam Banitorfi, Seyed Mostafa Hosseini, Sodabe Khodabandehlou, Fatemeh Nouri
Harnessing the Natural Toxic Metabolites in COVID-19. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Akram Oftadeh Harsin, Farzin Firozian, Meysam Soleimani, Fereshteh Mehri, Akram Ranjbar
Evaluation of Ascorbic Acid Niosomes as Potential Detoxifiers in Oxidative Stress-induced HEK-293 Cells by Arsenic Trioxide. Iranian journal of pharmaceutical research : IJPR 21 (1) (2022)
Akram Oftadeh Harsin, Farzin Firozian, Meysam Soleimani, Fereshteh Mehri, Akram Ranjbar
Evaluation of Ascorbic Acid Niosomes as Potential Detoxifiers in Oxidative Stress-induced HEK-293 Cells by Arsenic Trioxide. Iranian journal of pharmaceutical research : IJPR 21 (1) (2022)
Mohammad Ahmadi, Yaghoub Ahmadyousefi, Zahra Salimi, Rasoul Mirzaei, Rezvan Najafi, Bagher Amirheidari, Fatemeh Rahbarizadeh, Javad Kheshti, Armin Safari, Meysam Soleimani
Innovative Diagnostic Peptide-Based Technologies for Cancer Diagnosis: Focus on EGFR-Targeting Peptides. ChemMedChem (2022)
Maryam Shafaati, Massoud Saidijam, Meysam Soleimani, Fereshte Hazrati, Rasoul Mirzaei, Bagher Amirheidari, Hamid Tanzadehpanah, Sajad Karampoor, Sima Kazemi, Bahram Yavari, Hanie Mahaki, Mohsen Safaei, Fatemeh Rahbarizadeh, Pouria Samadi, Yaghoub Ahmadyousefi
A brief review on DNA vaccines in the era of COVID-19. Future virology (2021)
Fereshte Hazrati, Massoud Saidijam, Yaghoub Ahmadyousefi, Fatemeh Nouri, Hamidreza Ghadimipour, Mohammadreza Moradi, Rasool Haddadi, Meysam Soleimani
A novel chimeric protein with enhanced cytotoxic effects on breast cancer in vitro and in vivo. Proteins (2021)
Samin Hajian, Mehrdokht Mazdeh, Fatemeh Nouri, Ghodratollah Roshanaei, Meysam Soleimani
Association study of promoter polymorphisms of interferon alpha and beta receptor subunit 1 (IFNAR1) gene and therapeutic response to interferon-beta in patients with multiple sclerosis. Molecular biology reports 48 (8) (2021)
Bahareh Afra, Mojdeh Mohammadi, Meysam Soleimani, Reza Mahjub
Preparation, statistical optimization, in vitro characterization, and in vivo pharmacological evaluation of solid lipid nanoparticles encapsulating propolis flavonoids: a novel treatment for skin edema. Drug development and industrial pharmacy 46 (7) (2020)
Soheil Madadi, Meysam Soleimani
Comparison of miR-16 and cel-miR-39 as reference controls for serum miRNA normalization in colorectal cancer. Journal of cellular biochemistry 120 (4) (2019)